BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,130 filers reported holding BAXTER INTL INC in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $915,007 | +67.4% | 24,245 | +102.1% | 0.03% | +61.1% |
| Q2 2023 | $546,674 | +129137.4% | 11,999 | +15.0% | 0.02% | +38.5% |
| Q1 2023 | $423 | -19.0% | 10,433 | +1.9% | 0.01% | -40.9% |
| Q4 2022 | $522 | -100.0% | 10,240 | -78.5% | 0.02% | -47.6% |
| Q3 2022 | $2,567,000 | -20.0% | 47,646 | -4.6% | 0.04% | -41.7% |
| Q2 2022 | $3,207,000 | -51.1% | 49,924 | -41.0% | 0.07% | +14.3% |
| Q1 2022 | $6,560,000 | +129.4% | 84,598 | +153.9% | 0.06% | +28.6% |
| Q4 2021 | $2,860,000 | +25.4% | 33,317 | +17.5% | 0.05% | -15.5% |
| Q3 2021 | $2,280,000 | +138.2% | 28,347 | +138.4% | 0.06% | +132.0% |
| Q2 2021 | $957,000 | -77.2% | 11,892 | -76.1% | 0.02% | -64.8% |
| Q1 2021 | $4,192,000 | +219.5% | 49,714 | +203.9% | 0.07% | +77.5% |
| Q4 2020 | $1,312,000 | -2.4% | 16,357 | -2.1% | 0.04% | +166.7% |
| Q3 2020 | $1,344,000 | +227.8% | 16,705 | +250.4% | 0.02% | -11.8% |
| Q2 2020 | $410,000 | +110.3% | 4,767 | +98.7% | 0.02% | +41.7% |
| Q1 2020 | $195,000 | -82.3% | 2,399 | -81.0% | 0.01% | -84.2% |
| Q3 2019 | $1,102,000 | +252.1% | 12,596 | +229.2% | 0.08% | +261.9% |
| Q2 2019 | $313,000 | -46.5% | 3,826 | -46.8% | 0.02% | -40.0% |
| Q1 2019 | $585,000 | -50.6% | 7,194 | -60.0% | 0.04% | -58.8% |
| Q4 2018 | $1,184,000 | +66.5% | 17,985 | +95.0% | 0.08% | +63.5% |
| Q3 2018 | $711,000 | -21.7% | 9,223 | -25.0% | 0.05% | +2.0% |
| Q2 2018 | $908,000 | -7.4% | 12,305 | -18.4% | 0.05% | -39.3% |
| Q1 2018 | $981,000 | +216.5% | 15,080 | +214.8% | 0.08% | +110.0% |
| Q4 2017 | $310,000 | +573.9% | 4,791 | +553.6% | 0.04% | +900.0% |
| Q3 2017 | $46,000 | +2200.0% | 733 | +2121.2% | 0.00% | – |
| Q2 2017 | $2,000 | -77.8% | 33 | -81.5% | 0.00% | -100.0% |
| Q1 2017 | $9,000 | -97.9% | 178 | -98.2% | 0.00% | -97.9% |
| Q4 2016 | $437,000 | +8640.0% | 9,867 | +9767.0% | 0.05% | – |
| Q3 2016 | $5,000 | -98.1% | 100 | -98.4% | 0.00% | -100.0% |
| Q1 2016 | $264,000 | -19.8% | 6,408 | +36.4% | 0.04% | +34.5% |
| Q2 2015 | $329,000 | +32800.0% | 4,698 | +22271.4% | 0.03% | – |
| Q1 2015 | $1,000 | -99.9% | 21 | -99.9% | 0.00% | -100.0% |
| Q3 2014 | $1,199,000 | +122.9% | 16,701 | +128.3% | 0.13% | +94.2% |
| Q1 2014 | $538,000 | +1821.4% | 7,314 | +1728.5% | 0.07% | +1280.0% |
| Q4 2013 | $28,000 | -95.2% | 400 | -95.5% | 0.01% | -92.1% |
| Q3 2013 | $585,000 | +125.9% | 8,901 | +138.5% | 0.06% | +200.0% |
| Q2 2013 | $259,000 | – | 3,732 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |